AYTU · Aytu Biopharma, Inc
$2.16
+0.00 (+0.00%)
At close · Jul 24
Market Cap
$23.18M
Shares
10.73M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Joshua R. Disbrow | CEO | $883,928 |
| Jarrett T. Disbrow | Chief Business Officer | $549,247 |
| Ryan Selhorn | CFO | $538,646 |
| Greg Pyszczymuka | Chief Commercial Officer | $522,076 |
| Mark K. Oki | CFO | $238,387 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Joshua R. Disbrow | CEO | $928,217 |
| Mark K. Oki | CFO | $584,669 |
| Jarrett T. Disbrow | Chief Business Officer | $542,097 |
| Greg Pyszczymuka | Chief Commercial Officer | $516,301 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Joshua R. Disbrow | CEO | $708,000 |
| Greg Pyszczymuka | Chief Commercial Officer | $540,046 |
| Mark K. Oki | CFO | $522,840 |
| Jarrett T. Disbrow | Chief Business Officer | $454,992 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Joshua R. Disbrow | CEO | $590,000 |
| Mark K. Oki | CFO | $368,558 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Joshua R. Disbrow | CEO | $1,585,450 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Joshua R. Disbrow | CEO | $1,043,705 |
| Jarrett T. Disbrow | COO | $793,413 |
| David Green | CFO | $685,988 |
| Gregory A. Gould | CFO | — |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Joshua R. Disbrow | CEO | $606,000 |
| Jarrett T. Disbrow | COO | $452,000 |
| David Green | CFO | $287,000 |
| Gregory A. Gould | CFO | $96,000 |